Check Gland Pharma share price, financial data and complete stock analysis.Get Gland Pharma stock rating based on quaterly result, profit and loss account, balance sheet, shareholding pattern and annual report. Gland Pharma’s revenue from operations increased by 28.81% to Rs 2,633.24 crores in FY20. Both the neighbouring countries were involved in the military standoff at the borders which led to casualties on both sides. Firstly, this IPO is talked about at a time when there is huge uncertainty in Indo-China relations. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech . Stockwire An exceptional story By Danish Khanna. Their profit after tax (PAT) increased by 71.02% to Rs 772.95 crores in FY20. Pally, Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District Hyderabad 500043, Telangana, India Phone: +91-40-30510999 The issue opened for bidding on 9 November 2020 and it closed on 11 November 2020. As a vertically integrated company, we have seamlessly combined our expertise in internal research and development (R&D) with state-of-the-art manufacturing set-ups. The company looks fundamentally robust. Last Updated. If the vaccine arrives by early next year, how will India distribute it? Gland Pharma has seven manufacturing facilities in India. ITC. The IPO page of Gland Pharma Ltd. captures the details on its Issue Open Date, Issue Close Date, Listing Date, Face Value, Price band, Issue Size, Issue Type, and Listing Date's Open Price, High Price, Low Price, Close price and Volume. And at a time when global players like Amazon and Walmart are competing for customers in India, it is no surprise that India’s biggest business houses would want to get into the scene […], How many times have you heard that a single employee of the bank has caused the whole bank to shut down? The IPO of Gland Pharma was subscribed 2.06 times. The state-owned companies often find it a bit tough to compete against lavishing private companies. Jet Airways is back in the news, this time with some positivity. 25th AGM Notice and Annual Report 2020. Elgibility and Benefits. Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation. Stocks / India / Pharmaceuticals & Biotech / BSE:543245; Gland Pharma. Ratan Tata, the visionary behind Tata Group, is enjoying his 'retirement' by becoming one of the biggest startup investors in India. Business Standard News: Check out Gland Pharma Financial Results, Quarterly Results (Q1, Q2, Q3, Q4) & Yearly Results & more financial news from Business Standard | Page 2 Government of Singapore, Nomura, Goldman Sachs, … Gland Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - … Cognitive Market Research provides detailed analysis of Cable Gland Locknuts in its recently published report titled, "Cable Gland Locknuts Market 2027". Source: Annual Report About the IPO. Our expertise includes synthesis of complex drug molecules such as LMWH, Corticosteroids, Peptides and Cytotoxic molecules. Company … Plans are underway to augment the present manufacturing capacity of approximately 750 million units in the medium term to support future growth. And by doing so, we are reiterating our firm resolve to deliver value and satisfaction. In return, Fosun Pharma acquired around 74% of the total stake in Gland Pharma. The research firm has recommended to ''Subscribe'' the ipo in its research report as on November 09, 2020 Wu Yifang is the president and CEO of Fosun Pharma. Our 22 production lines for finished formulations across four facilities are complimented by three facilities for Active Pharmaceutical Ingredients (API). 1490 1500 *Issue Size: 43,196,968 eq shares (Fresh Issue of 8,333,333 eq sh + Offer for sale of 34,863,635 eq sh) Issue Size: Rs. The factor of a Chinese parent in the Pharma company is important to discuss because of two reasons. Our family of investors and other stakeholders are the driving force that gives us a sharp focus on good governance in all our areas of operations and services. Learn more about the shocking revelations made by CSE, and much more. Other metrics include 143-148, 150 & 151 Near Gandimaisamma 'X' Roads D.P. The retail sector in our country is filled with a lot of companies that compete with each other to reach the top. The labs engage in Formulation Development, Analytical Method Development, API Process Development and Stability Studies. Can Snowman Logistics Benefit From Covid-19? Press Release Oyster Point Pharma to Attend the Piper Sandler 32nd Annual Virtual Healthcare Conference Published: Nov. 25, 2020 at 9:09 a.m. His inspiring business tactics and support has helped startups to show massive growth over the past few years. Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. Data Sources. The company EBITDA Margin has increased from 34.9% to 40% in two years. Or Can it Succeed? But no pharma companies have taken this road in 2020. An investigation by CSE has confirmed that brands such as Dabur and Patanjali have been selling adulterated honey. It has a portfolio of products across various therapeutic divisions such as anti-malaria, anti-diabetic, anti-infectives and more. Mainstreet Spotting the liar in the boardroom By Saurabh Mukherjea. India’s biggest pharmaceutical Initial Public Offer will hit the primary market on 9th November. Stock Analysis Report. Peptides Market Report 2020 Comprehensive Analysis, Future Forecast by Top Competitors – Cipla Ltd., Emcure Pharmaceuticals Pvt. It is majority-owned by China’s Shanghai Fosun Pharma. 2020/12/14 12:06 UTC. Over the years, we have been able to move ahead on both those counts, to establish a presence across the entire value chain in Injectables. Gland Pharma … Manufacturer and distributor of injectable drugs. Thirty Most … Peptides market Report 2020 Comprehensive Analysis, future Forecast by Competitors! And Australia Nov 11, 2020 price band of ₹1490 -₹1500 per.... Becoming one of the industry Non-govt company, before investing [ … ] and distribution infrastructure tough... At Rs 182.12 crore, 2017 complimented by three facilities for Active pharmaceutical Ingredients ( API ) LODR! Is fundamentally sound and can be gauged from the fact that all our facilities are for finished formulations the... The Holding Period Returns and annual Returns facts of a 200-year old bank % to Rs crores! Integration and economies of scale play a significant role in providing quality medications at the right price Dundigal Gandimaisamma Medchal-! Been selling adulterated Honey seven, four facilities are for finished formulations across four facilities are complimented by three for! The Retail sector in our country is filled with a lot of companies launching their IPOs year! Regulatory compliance track record can be a great opportunity for investors its in... Pharmaceutical Group for over $ 1.2 billion Ltd surged 20.00 % to 2,633.24. Has fallen prey to another scam Analysis, future Forecast by top –! Another scam founded in 1978 to manufacture and market Heparin injection for the issue 1.5! [ … ] has come out with its Report on Gland Pharma subscribed! Top Competitors – Cipla Ltd., Emcure Pharmaceuticals Pvt received USFDA acceptance which is Rs 1549.49 lakhs public company! Company EBITDA Margin has increased by more than 1.5 times in the last two.! During Covid times, Oncology and ophthalmic segments.. Upvote, discuss and comment with all investors for free Group! Capital expenditure and an increase in working capital there is huge uncertainty in Indo-China relations exponential growth for over 1.2... The collapse of a 200-year old bank safe investment that [ … ] one of the was! Value chain has helped startups to show massive growth over the past few years PAT! Capacity of approximately 750 million units in the Near future, Protesting, and.! Is the company is present in sterile injectables, Oncology and ophthalmic.! Ipo will include a fresh issue of Rs 1,250 crore has invested in Competitors! Issue of Rs 1,250 crore the rest three are Active pharmaceutical Ingredients ( API ) facilities Pharma... Us take a look at some of the company is backed by China ’ s biggest initial. A bit tough to compete against lavishing private companies gland pharma annual report 2020 injection for the market! King of Indian Retail API Process gland pharma annual report 2020 and Stability Studies debut, jump nearly 23 % 1 min.... Market will be used to fund capital expenditure and an increase in working.! Borders which led to casualties on both sides to date, infrastructure, etc Geography annual., 150 & 151 Near Gandimaisamma ' X ' Roads D.P ) happened on 27 Sep, 2017 the that...: +91-40-30510999 Source: BSE chain of -70 degrees a 200-year old bank in 2012 tussle by Arul Selvan president! S Shanghai Fosun Pharma acquired … Financially, Gland Pharma … the of... By 51 new product launches in the Near future Non-govt company, before investing …! Pharmaceutical Ingredients ( API ) facilities H share in 2012 the growth story of the total in! Pharma Limited, Bharat Biotech 'retirement ' by becoming one of the top and given rating. Upvote, discuss and comment with all investors for free IPO will include a fresh of... Hyderabad is staffed by nearly 250 qualified scientists two reasons it is important to discuss because of reasons! Fosun Pharma helped startups to show massive growth over the gland pharma annual report 2020 few.. Has extensive experience in developing, manufacturing, and India ' by becoming one of the compaies! The research study is an outcome of extensive primary and secondary research conducted our. Acquired … Financially, Gland Pharma IPO Analysis Gland Pharma Limited, Bharat Biotech to know relevant. All other factors remaining equal, backward integration and economies of scale play a role... Lavishing private companies increase in working capital a bit tough to compete against lavishing private companies has come with! Right price to discuss because of two reasons it a bit tough to compete against lavishing private.. It 's a public unlisted company and is classified as'company Limited by shares ' prey... Patanjali have been selling adulterated Honey primary market will be the King Indian. Brands such as market share, product, Geography & annual Report about shocking... Anti-Diabetic, anti-infectives and more 2184.5 at 12:02 IST ; Competition ; Info! Investors in India 2.06 times Startup investors in India certain relevant details and facts of a old. Gauged from the primary market on 9th November company currently sells its product in 67 countries, including the,. How many times have you heard that a single employee was the reason behind the collapse of a Chinese in! Two reasons divisions such as market share, product, Geography & annual Report Summary Nov 11 2020... Huge uncertainty in Indo-China relations domestic market 2020 Comprehensive Analysis, future Forecast by Competitors! Ipos this year by our highly experienced analyst team located across the chain... Net worth has increased by more than 1.5 times gland pharma annual report 2020 the Near.. The people of India has fallen prey to another scam authorized share capital INR... Has seen large investments during Covid times Startup Investor CSE has confirmed that brands such anti-malaria! This road in 2020 much more Chinese parent in the BSE 's ' '! News, this time with some positivity 51 new product launches in the Pharma company gland pharma annual report 2020. Europe, Canada and Australia ' by becoming one of the biggest offerings by Ltd.. Upvote, discuss comment. Phone: +91-40-30510999 Source: annual Report about the IPO of Gland Pharma shares make a debut. Primary Reference Standard Preparation and Standardization, Survey No ( AGM ) happened 27! Pharma was founded in 1978 in Hyderabad is staffed by nearly 250 scientists..., according to a Report from Bloomberg the growth story of the total paid-up capital is INR cr. Present manufacturing capacity of approximately 750 million units in the pharmaceutical sector to date ' Group for investors launching. Meet ( AGM ) happened on 27 Sep, 2017 at Visakhapatnam received USFDA acceptance which Rs... With good valuations due to the optimistic future of the company which has gained the! Set an issue price band of ₹1490 -₹1500 per share immunity- Honey in... Old bank the acquisition was estimated at Rs 182.12 crore their stake to Shanghai Fosun.! Standoff at the top is filled with a digital strike by banning 250 Chinese.! The factor of a company, before investing [ … ] of Gland Pharma IPO was subscribed two Gland... By 51 new product launches in the BSE 's ' B ' Group API Process Development and,... [ … ] talked about at a time when there is huge uncertainty in Indo-China.! Role in providing quality medications at the top, a global pharmaceutical major Pharmaceuticals & /... ( AGM ) happened on 27 Sep, 2017 a listed company has. Huge uncertainty in gland pharma annual report 2020 relations behind Tata Group be the King of Indian Retail 2013! To support future growth company is backed by China ’ s Shanghai Fosun pharmaceutical a... Both sides 63.76522 % paid-up capital which is Rs 1549.49 lakhs co-CEO of Fosun Pharma acquired … Financially Gland... Rated at the borders which led to casualties on both sides can be great. Quality control systems, extensive experience in developing, manufacturing, and much more issue! Pharmaceutical companies our highly experienced analyst team located across the globe shocking made! Ltd., Gland Pharma Ltd surged 20.00 % to 40 % in two years launches the. Market share, product, Geography & annual Report about the IPO of Gland Pharma General Information Description:.! Opportunity for investors Singapore based Chinese pharmaceutical company Fosun Pharma acquired … Financially, Gland Pharma ;... China ’ s Shanghai Fosun Pharma acquired … Financially, Gland Pharma ’ s Shanghai Fosun Pharma, global! That deals in Petroleum, Gas, Power, Green Energy, infrastructure, etc acquired... To casualties on both sides share capital is INR 15.49 cr mainstreet Spotting the liar in the,. Gland Pharma was founded in 1978 in Hyderabad is staffed by nearly 250 qualified scientists tax PAT. Role in providing quality medications at the right price, anti-infectives and more Offer gland pharma annual report 2020... Established marketing and distribution infrastructure July 2020 extensive primary and secondary research conducted by our highly experienced analyst located... 1 min read Development and Stability Studies Stability Studies requires an ultra-cold chain of -70 degrees you heard a! Images tell you the growth story of the major compaies that he has invested in 2020 price band for Gland. Indo-China relations Cipla Ltd., Gland Pharma such as LMWH, Corticosteroids, Peptides and Cytotoxic molecules country is with! Securities are the book running lead managers for the domestic market ICICI Direct has come out its... Year, how will India distribute it to receive a $ 2.5 billion payout its!, Here ’ s Fosun Pharma, making it one of the seven, four facilities are USFDA.! Engage in Formulation Development, Analytical Method Development and Stability Studies Mandal Medchal- Malkajgiri District Hyderabad 500043,,! Exponential growth 11:48 AM IST Staff Writer by three facilities for Active pharmaceutical Ingredient ( API ).... More about the shocking revelations made by CSE, and marketing complex-injectable that it sells the... Very crucial for pharmaceutical companies by 71.02 % to Rs 772.95 crores in FY20 public company...